Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome

2006 ◽  
Vol 31 (4) ◽  
pp. 375-383 ◽  
Author(s):  
G. Derosa ◽  
A. D'Angelo ◽  
P. D. Ragonesi ◽  
L. Ciccarelli ◽  
M. N. Piccinni ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document